• +1-646-491-9876
    • +91-20-67278686

    Search

    End - Stage Kidney Disease (End - Stage Renal Disease or ESRD) - Pipeline Insights, 2017

    End - Stage Kidney Disease (End - Stage Renal Disease or ESRD) - Pipeline Insights, 2017

    • Report Code ID: RW0001545997
    • Category Pharmaceuticals
    • No. of Pages 60
    • Publication Month Jan-17
    • Publisher Name DelveInsight
    Publisher's, "End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Publisher's Report also assesses the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

    Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

    Report Scope

    - The report provides competitive pipeline landscape of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
    - The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
    - Coverage of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
    - The report reviews key players involved in the therapeutics development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) and also provide company profiling
    - The report also gives the information of dormant and discontinued pipeline projects
    - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
    - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Overview
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Pipeline Therapeutics
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics under Development by Companies
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Filed and Phase III Products
    - Comparative Analysis
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Phase II Products
    - Comparative Analysis
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Phase I and IND Filed Products
    - Comparative Analysis
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Discovery and Pre-Clinical Stage Products
    - Comparative Analysis
    - Drug Candidate Profiles
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics Assessment
    - Assessment by Monotherapy Products
    - Assessment by Combination Products
    - Assessment by Route of Administration
    - Assessment by Molecule Type
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Discontinued Products
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Dormant Products
    - Companies Involved in Therapeutics Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
    - Appendix
    - Methodology
    - Contact Us
    - Disclaimer


    List of Tables


    - Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), 2017
    - Number of Products under Development by Companies
    - Comparative Analysis by Filed and Phase III Products, 2017
    - Comparative Analysis Phase II Products, 2017
    - Comparative Analysis Phase I and IND Filed Products, 2017
    - Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
    - Drug Candidates Profiles
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Monotherapy Products
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Combination Products
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Route of Administration
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Route of Administration
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Molecule Type
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Molecule Type
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics - Discontinued Products
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics - Dormant Products
    - Products under Development by Companies, 2017


    List of Figures


    - Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), 2017
    - Filed and Phase III Products, 2017
    - Phase II Products, 2017
    - Phase I and IND Filed Products, 2017
    - Discovery and Pre-Clinical Stage Products, 2017
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Monotherapy Products
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Combination Products
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Route of Administration
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Route of Administration
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Molecule Type
    - End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Assessment by Stage and Molecule Type


    Request for Sample

    Report Url http://www.reportsweb.com//end-stage-kidney-disease-end-stage-renal-disease-or-esrd-pipeline-insights-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//end-stage-kidney-disease-end-stage-renal-disease-or-esrd-pipeline-insights-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//end-stage-kidney-disease-end-stage-renal-disease-or-esrd-pipeline-insights-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments